These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9339474)

  • 21. Environmental endocrine disrupters.
    Toppari J
    Sex Dev; 2008; 2(4-5):260-7. PubMed ID: 18987500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A treatise on hazards of endocrine disruptors and tool to evaluate them.
    Roy P; Pereira BM
    Indian J Exp Biol; 2005 Nov; 43(11):975-92. PubMed ID: 16313061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine targets in experimental shock.
    Chaudry IH; Samy TS; Schwacha MG; Wang P; Rue LW; Bland KI
    J Trauma; 2003 May; 54(5 Suppl):S118-25. PubMed ID: 12768113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of sex and hormonal status on the physiological response to acute psychosocial stress.
    Kajantie E; Phillips DI
    Psychoneuroendocrinology; 2006 Feb; 31(2):151-78. PubMed ID: 16139959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis.
    Clerico A; Fontana M; Vittorini S; Emdin M
    Clin Chim Acta; 2009 Jul; 405(1-2):1-7. PubMed ID: 19341716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine disruption in aquatic vertebrates.
    Kloas W; Urbatzka R; Opitz R; Würtz S; Behrends T; Hermelink B; Hofmann F; Jagnytsch O; Kroupova H; Lorenz C; Neumann N; Pietsch C; Trubiroha A; Van Ballegooy C; Wiedemann C; Lutz I
    Ann N Y Acad Sci; 2009 Apr; 1163():187-200. PubMed ID: 19456339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
    Kliewer SA; Lehmann JM; Milburn MV; Willson TM
    Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine considerations in toxicologic pathology.
    Iatropoulos MJ
    Exp Toxicol Pathol; 1994 Feb; 45(7):391-410. PubMed ID: 8167462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Perspectives on endocrine disruption].
    Olea N; Fernández MF; Araque P; Olea-Serrano F
    Gac Sanit; 2002; 16(3):250-6. PubMed ID: 12057182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine disruptors.
    Pombo M; Castro-Feijóo L
    J Pediatr Endocrinol Metab; 2005 Dec; 18 Suppl 1():1145-55. PubMed ID: 16398443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive toxicology: the science today.
    Neubert D
    Teratog Carcinog Mutagen; 2002; 22(3):159-74. PubMed ID: 11948627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotoxic effects of endocrine disruptors.
    Laessig SA; McCarthy MM; Silbergeld EK
    Curr Opin Neurol; 1999 Dec; 12(6):745-51. PubMed ID: 10676759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of environmental hormones on reproduction.
    Danzo BJ
    Cell Mol Life Sci; 1998 Nov; 54(11):1249-64. PubMed ID: 9849617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DIAGNOSIS OF ENDOCRINE DISEASE: Drug-induced endocrinopathies and diabetes: a combo-endocrinology overview.
    Diamanti-Kandarakis E; Duntas L; Kanakis GA; Kandaraki E; Karavitaki N; Kassi E; Livadas S; Mastorakos G; Migdalis I; Miras AD; Nader S; Papalou O; Poladian R; Popovic V; Rachoń D; Tigas S; Tsigos C; Tsilchorozidou T; Tzotzas T; Bargiota A; Pfeifer M
    Eur J Endocrinol; 2019 Aug; 181(2):R73-R105. PubMed ID: 31242462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hazard identification and risk assessment of endocrine disrupting chemicals with regard to developmental effects.
    Mantovani A
    Toxicology; 2002 Dec; 181-182():367-70. PubMed ID: 12505338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroimmunoendocrine effects of ethanol in the development of pathology of internal organs].
    Rapoport SI; Kvetnoĭ IM; Il'nitskiĭ AN; Proshchaev KI; Zhernakova NI; Pozharskis A; Medvedev DS; Gurko GI; Perelygin KV
    Klin Med (Mosk); 2012; 90(3):8-12. PubMed ID: 22690557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine disruptors as a threat to neurological function.
    Weiss B
    J Neurol Sci; 2011 Jun; 305(1-2):11-21. PubMed ID: 21474148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the risks of adverse endocrine-mediated effects: where to from here?
    Ashby J; Odum J; Tinwell H; Lefevre PA
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):80-93. PubMed ID: 9339484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the human health effects of chemical mixtures.
    Carpenter DO; Arcaro K; Spink DC
    Environ Health Perspect; 2002 Feb; 110 Suppl 1(Suppl 1):25-42. PubMed ID: 11834461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine active compounds: from biology to dose response assessment.
    Barton HA; Andersen ME
    Crit Rev Toxicol; 1998 Jul; 28(4):363-423. PubMed ID: 9711433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.